Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 227,855 | 292,065 | 416,668 | 291,377 | 281,607 |
| Marketable Securities | 1,827 | 2,020 | 2,252 | 2,310 | 2,847 |
| Receivables | 594 | 400 | N/A | 300 | 250 |
| Income taxes - deferred | N/A | N/A | N/A | 375 | N/A |
| Other current assets | 67,246 | 64,797 | 63,439 | 57,597 | 55,289 |
| TOTAL | $306,688 | $367,097 | $500,667 | $355,897 | $341,439 |
| Non-Current Assets | |||||
| PPE Net | 42 | 42 | 52 | 62 | 72 |
| Intangibles | 384,572 | 280,731 | 269,668 | 259,244 | 242,452 |
| Other Non-Current Assets | 329,299 | 347,671 | 343,746 | 347,147 | 395,906 |
| TOTAL | $713,913 | $628,444 | $613,466 | $606,453 | $638,430 |
| Total Assets | $1,020,601 | $995,541 | $1,114,133 | $962,350 | $979,869 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 50,263 | 75,349 | 100,008 | 318 | 19,799 |
| TOTAL | $94,589 | $143,943 | $342,748 | $187,983 | $261,639 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 330,055 | 324,384 | 319,441 | 313,930 | 316,224 |
| TOTAL | $330,055 | $324,384 | $319,441 | $313,930 | $316,224 |
| Total Liabilities | $424,644 | $468,327 | $662,189 | $501,913 | $577,863 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 163,575 | 164,178 | 164,092 | 162,751 | 160,654 |
| Common Shares | 1,636 | 1,636 | 1,635 | 1,622 | 1,603 |
| Retained earnings | 709,470 | 640,024 | 561,785 | 575,740 | 520,976 |
| Other shareholders' equity | 3,391 | 4,715 | 7,910 | 2,949 | -393 |
| TOTAL | $595,957 | $527,214 | $451,944 | $460,437 | $402,006 |
| Total Liabilities And Equity | $1,020,601 | $995,541 | $1,114,133 | $962,350 | $979,869 |